3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Peritoneal Neoplasms
10
Colorectal Neoplasms
8
Stomach Neoplasms
6
Ovarian Neoplasms
4
Gastrointestinal Neoplasms
3
Colonic Neoplasms
3
Appendiceal Neoplasms
3
Sarcoma
2
Rhabdomyosarcoma
2
Neoplasms
2
Mesothelioma
2
Desmoplastic Small Round Cell Tumor
2
Wilms Tumor
1
Retroperitoneal Neoplasms
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Liposarcoma
1
Hyperthermia
1
Gastric Adenocarcinoma
1
Fallopian Tube Neoplasms
1
Colorectal Cancer Metastatic
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Adrenocortical Carcinoma
1
Adenoma, Islet Cell
1
Interventions
Fluorouracil
98
Oxaliplatin
94
Leucovorin
86
Irinotecan
70
Gemcitabine
66
Bevacizumab
62
Capecitabine
60
Cetuximab
42
pembrolizumab
37
Cisplatin
30
Nivolumab
25
Drug Therapy
25
130-nm albumin-bound paclitaxel
22
Specimen Handling
20
Folfox protocol
20
Panitumumab
19
Paclitaxel
19
Magnetic Resonance Spectroscopy
18
Albumin-Bound Paclitaxel
17
Biopsy
16
IFL protocol
15
Floxuridine
15
Docetaxel
15
Cyclophosphamide
15
Sorafenib
14
regorafenib
12
Erlotinib Hydrochloride
12
aflibercept
11
Radiofrequency Ablation
11
fludarabine
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Cytoreduction Surgical Procedures
×
Gastrointestinal
×
Clear all
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled